Copaiba

Copaiba oleoresin contains beta-caryophyllene, a sesquiterpene that acts as a selective agonist at CB2 cannabinoid receptors. Unlike THC, beta-caryophyllene does not produce psychoactive effects. When CB2 receptors are activated, they modulate immune cell activity and reduce pro-inflammatory cytokine production. This mechanism explains Copaiba's documented anti-inflammatory and analgesic properties. Additional compounds including copalic acid and kaurenoic acid contribute to its therapeutic effects. Evidence level C supports these mechanisms based on pharmacological studies and traditional use.

There is limited clinical research on Copaiba drug interactions. Due to its metabolism in the liver, Copaiba may theoretically interact with medications processed by similar pathways. Caution is advised when combining with anti-inflammatory drugs, diuretics, or medications affecting kidney function, as Copaiba can cause kidney irritation at high doses. Patients taking prescription medications should consult a healthcare provider before using Copaiba supplements. Evidence level C reflects the lack of formal interaction studies.

The typical adult dosage for Copaiba oleoresin is 1-2ml daily taken in capsule form. For topical application, 2-3 drops applied to the affected area is standard practice. Copaiba should not be taken internally in large doses due to potential kidney irritation. Dosage recommendations are based on traditional use, as standardized clinical trials establishing optimal dosing are limited. Evidence level C applies. Start with lower doses and adjust based on individual tolerance.

Copaiba is contraindicated during pregnancy and should be avoided entirely. The oleoresin contains compounds that may stimulate uterine contractions or affect fetal development. There is insufficient safety data to support its use in pregnant or breastfeeding women. Women who are pregnant, planning pregnancy, or breastfeeding should not use Copaiba internally or topically. This contraindication is based on traditional knowledge and the pharmacological properties of the active diterpenes.

Common side effects of Copaiba include nausea, diarrhea, and gastrointestinal discomfort, particularly when taken internally. Topical application may cause skin irritation or allergic reactions in sensitive individuals. Large or prolonged doses can irritate the kidneys and should be avoided, especially in those with pre-existing kidney disease. People with gastrointestinal sensitivity should use caution. Discontinue use if adverse reactions occur. Evidence level C indicates these effects are documented from traditional use and case reports.